Prognostic importance of plasma NT-pro BNP in chronic heart failure in patients treated with a beta-blocker: results from the Carvedilol Or Metoprolol European Trial (COMET) trial
Academic Article
Publication Date:
2007
Short description:
Prognostic importance of plasma NT-pro BNP in chronic heart failure in patients treated with a beta-blocker: results from the Carvedilol Or Metoprolol European Trial (COMET) trial / Olsson, Lg; Swedberg, K; Cleland, Jg; Spark, Pa; Komajda, M; Metra, Marco; Torp Pedersen, C; Remme, Wj; Scherhag, A; Poole Wilson, P; Comet, Investigators. - In: EUROPEAN JOURNAL OF HEART FAILURE. - ISSN 1388-9842. - 9(8):(2007), pp. 795-801.
Iris type:
1.1 Articolo in rivista
List of contributors:
Olsson, Lg; Swedberg, K; Cleland, Jg; Spark, Pa; Komajda, M; Metra, Marco; Torp Pedersen, C; Remme, Wj; Scherhag, A; Poole Wilson, P; Comet, Investigators
Published in: